Status:
UNKNOWN
Surveillance of Vaccine-induced Immunity Against Ebola in Previously Vaccinated Health Care Workers
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Conditions:
Immune Response
Eligibility:
All Genders
18+ years
Brief Summary
During the previous Ebola virus disease (EVD) outbreaks, the institute National de Recherche Biomédicale (INRB) and other institutional's staff in Democratic Republic of the Congo (DRC) got vaccinated...
Detailed Description
Despite the availability of new effective therapeutics, Ebola Virus Disease (EVD) remains a highly lethal disease, with significant collateral impact on the society. In addition, during the last decad...
Eligibility Criteria
Inclusion
- Subject is willing and able to give informed consent for participation in the study
- Subject can be contacted by phone, email or physical address
- Subject is aged 18 years or above
- Subject must have a ID card (or other identification document)
- For vaccinated group:
- \- Subject must be receiving the rVSV-ZEBOV vaccine (first or second dose) at time of inclusion OR has received a first rVSV-ZEBOV vaccine dose prior to inclusion of which vaccination date and brand is known
- For unvaccinated group (controls):
- Subject must NOT have received the rVSV-ZEBOV vaccine nor had any prior close contact with EBOV patients
Exclusion
- Subject was previously diagnosed with EVD
- Subject has any contraindication to venipuncture, as determined by clinical judgement
Key Trial Info
Start Date :
December 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT05313139
Start Date
December 13 2021
End Date
December 31 2022
Last Update
May 19 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut National de Recherche Biomédicale (INRB)
Goma, Democratic Republic of the Congo
2
Institut National de Recherche Biomédicale (INRB)
Kinshasa, Democratic Republic of the Congo